EMPOWERing Patients With Diabetes Using Profiling and Targeted Feedbacks Delivered Through Smartphone App and Wearable (EMPOWER): Protocol for a Randomized Controlled Trial on Effectiveness and Implementation

IntroductionType 2 diabetes mellitus (T2DM) poses huge burden and cost on the healthcare system. Mobile health (mHealth) interventions that incorporate wearables may be able to improve diabetes self-management. The aim of this randomized controlled trial (RCT) is to investigate the clinical and cost...

Full description

Bibliographic Details
Main Authors: Yu Heng Kwan, Sungwon Yoon, Chuen Seng Tan, Bee Choo Tai, Wee Boon Tan, Jie Kie Phang, Ngiap Chuan Tan, Cynthia Yan Ling Tan, Yan Ling Quah, David Koot, Hock Hai Teo, Lian Leng Low
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.805856/full
_version_ 1818331019682512896
author Yu Heng Kwan
Yu Heng Kwan
Yu Heng Kwan
Sungwon Yoon
Sungwon Yoon
Chuen Seng Tan
Chuen Seng Tan
Bee Choo Tai
Bee Choo Tai
Wee Boon Tan
Jie Kie Phang
Ngiap Chuan Tan
Ngiap Chuan Tan
Cynthia Yan Ling Tan
Yan Ling Quah
David Koot
Hock Hai Teo
Lian Leng Low
Lian Leng Low
Lian Leng Low
Lian Leng Low
Lian Leng Low
author_facet Yu Heng Kwan
Yu Heng Kwan
Yu Heng Kwan
Sungwon Yoon
Sungwon Yoon
Chuen Seng Tan
Chuen Seng Tan
Bee Choo Tai
Bee Choo Tai
Wee Boon Tan
Jie Kie Phang
Ngiap Chuan Tan
Ngiap Chuan Tan
Cynthia Yan Ling Tan
Yan Ling Quah
David Koot
Hock Hai Teo
Lian Leng Low
Lian Leng Low
Lian Leng Low
Lian Leng Low
Lian Leng Low
author_sort Yu Heng Kwan
collection DOAJ
description IntroductionType 2 diabetes mellitus (T2DM) poses huge burden and cost on the healthcare system. Mobile health (mHealth) interventions that incorporate wearables may be able to improve diabetes self-management. The aim of this randomized controlled trial (RCT) is to investigate the clinical and cost-effectiveness of personalized educational and behavioral interventions delivered through an EMPOWER mobile application (app) among patients with T2DM.MethodsThis is a parallel two-arm randomized controlled trial (RCT). Patients with T2DM recruited from primary care will be randomly allocated in a 1:1 ratio to either intervention or control group. The intervention group will receive personalized educational and behavioral interventions through the EMPOWER app in addition to their usual clinical care. The control group will receive the usual clinical care for their T2DM but will not have access to the EMPOWER app. Our primary outcome is patient activation score at 12 months. Secondary outcomes will include HbA1c, physical activity level and diet throughout 12 months; quality of life (QoL), medication adherence, direct healthcare cost and indirect healthcare cost at 6 and 12 months.DiscussionThis RCT will provide valuable insights into the effectiveness and implementation of personalized educational and behavioral interventions delivered through mobile application in T2DM management. Findings from this study can help to achieve sustainable and cost-effective behavioral change in patients with T2DM, and this can be potentially scaled to other chronic diseases such as hypertension and dyslipidemia.
first_indexed 2024-12-13T13:13:12Z
format Article
id doaj.art-28c4c43451074a59bc3d987b0695ce00
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-12-13T13:13:12Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-28c4c43451074a59bc3d987b0695ce002022-12-21T23:44:37ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-02-011010.3389/fpubh.2022.805856805856EMPOWERing Patients With Diabetes Using Profiling and Targeted Feedbacks Delivered Through Smartphone App and Wearable (EMPOWER): Protocol for a Randomized Controlled Trial on Effectiveness and ImplementationYu Heng Kwan0Yu Heng Kwan1Yu Heng Kwan2Sungwon Yoon3Sungwon Yoon4Chuen Seng Tan5Chuen Seng Tan6Bee Choo Tai7Bee Choo Tai8Wee Boon Tan9Jie Kie Phang10Ngiap Chuan Tan11Ngiap Chuan Tan12Cynthia Yan Ling Tan13Yan Ling Quah14David Koot15Hock Hai Teo16Lian Leng Low17Lian Leng Low18Lian Leng Low19Lian Leng Low20Lian Leng Low21Department of Pharmacy, National University of Singapore, Singapore, SingaporeProgram in Health Services and Systems Research, Duke-NUS Medical School, Singapore, SingaporeSingHealth Internal Medicine Residency Programme, Singapore, SingaporeProgram in Health Services and Systems Research, Duke-NUS Medical School, Singapore, SingaporeCentre for Population Health Research and Implementation, SingHealth Regional Health System, SingHealth, Singapore, SingaporeSaw Swee Hock School of Public Health, National University of Singapore, National University Health System, Singapore, SingaporeYong Loo Lin School of Medicine National University of Singapore, National University Health System, Singapore, SingaporeSaw Swee Hock School of Public Health, National University of Singapore, National University Health System, Singapore, SingaporeYong Loo Lin School of Medicine National University of Singapore, National University Health System, Singapore, SingaporePopulation Health and Integrated Care Office, Singapore General Hospital, Singapore, SingaporeCentre for Population Health Research and Implementation, SingHealth Regional Health System, SingHealth, Singapore, SingaporeSingHealth Polyclinics, Singapore, SingaporeSingHealth Duke-NUS Family Medicine Academic Clinical Program, Duke-NUS Medical School, Singapore, SingaporeSingHealth Polyclinics, Singapore, SingaporeSingHealth Polyclinics, Singapore, SingaporeSingHealth Polyclinics, Singapore, Singapore0School of Computing, National University of Singapore, Singapore, SingaporeCentre for Population Health Research and Implementation, SingHealth Regional Health System, SingHealth, Singapore, SingaporePopulation Health and Integrated Care Office, Singapore General Hospital, Singapore, SingaporeSingHealth Duke-NUS Family Medicine Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore1SingHealth Community Hospital, Singapore, Singapore2Department of Family Medicine and Continuing Care, Singapore General Hospital, Singapore, SingaporeIntroductionType 2 diabetes mellitus (T2DM) poses huge burden and cost on the healthcare system. Mobile health (mHealth) interventions that incorporate wearables may be able to improve diabetes self-management. The aim of this randomized controlled trial (RCT) is to investigate the clinical and cost-effectiveness of personalized educational and behavioral interventions delivered through an EMPOWER mobile application (app) among patients with T2DM.MethodsThis is a parallel two-arm randomized controlled trial (RCT). Patients with T2DM recruited from primary care will be randomly allocated in a 1:1 ratio to either intervention or control group. The intervention group will receive personalized educational and behavioral interventions through the EMPOWER app in addition to their usual clinical care. The control group will receive the usual clinical care for their T2DM but will not have access to the EMPOWER app. Our primary outcome is patient activation score at 12 months. Secondary outcomes will include HbA1c, physical activity level and diet throughout 12 months; quality of life (QoL), medication adherence, direct healthcare cost and indirect healthcare cost at 6 and 12 months.DiscussionThis RCT will provide valuable insights into the effectiveness and implementation of personalized educational and behavioral interventions delivered through mobile application in T2DM management. Findings from this study can help to achieve sustainable and cost-effective behavioral change in patients with T2DM, and this can be potentially scaled to other chronic diseases such as hypertension and dyslipidemia.https://www.frontiersin.org/articles/10.3389/fpubh.2022.805856/fullrandomized controlled trialdiabetessmartphone applicationprotocolnudge
spellingShingle Yu Heng Kwan
Yu Heng Kwan
Yu Heng Kwan
Sungwon Yoon
Sungwon Yoon
Chuen Seng Tan
Chuen Seng Tan
Bee Choo Tai
Bee Choo Tai
Wee Boon Tan
Jie Kie Phang
Ngiap Chuan Tan
Ngiap Chuan Tan
Cynthia Yan Ling Tan
Yan Ling Quah
David Koot
Hock Hai Teo
Lian Leng Low
Lian Leng Low
Lian Leng Low
Lian Leng Low
Lian Leng Low
EMPOWERing Patients With Diabetes Using Profiling and Targeted Feedbacks Delivered Through Smartphone App and Wearable (EMPOWER): Protocol for a Randomized Controlled Trial on Effectiveness and Implementation
Frontiers in Public Health
randomized controlled trial
diabetes
smartphone application
protocol
nudge
title EMPOWERing Patients With Diabetes Using Profiling and Targeted Feedbacks Delivered Through Smartphone App and Wearable (EMPOWER): Protocol for a Randomized Controlled Trial on Effectiveness and Implementation
title_full EMPOWERing Patients With Diabetes Using Profiling and Targeted Feedbacks Delivered Through Smartphone App and Wearable (EMPOWER): Protocol for a Randomized Controlled Trial on Effectiveness and Implementation
title_fullStr EMPOWERing Patients With Diabetes Using Profiling and Targeted Feedbacks Delivered Through Smartphone App and Wearable (EMPOWER): Protocol for a Randomized Controlled Trial on Effectiveness and Implementation
title_full_unstemmed EMPOWERing Patients With Diabetes Using Profiling and Targeted Feedbacks Delivered Through Smartphone App and Wearable (EMPOWER): Protocol for a Randomized Controlled Trial on Effectiveness and Implementation
title_short EMPOWERing Patients With Diabetes Using Profiling and Targeted Feedbacks Delivered Through Smartphone App and Wearable (EMPOWER): Protocol for a Randomized Controlled Trial on Effectiveness and Implementation
title_sort empowering patients with diabetes using profiling and targeted feedbacks delivered through smartphone app and wearable empower protocol for a randomized controlled trial on effectiveness and implementation
topic randomized controlled trial
diabetes
smartphone application
protocol
nudge
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.805856/full
work_keys_str_mv AT yuhengkwan empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT yuhengkwan empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT yuhengkwan empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT sungwonyoon empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT sungwonyoon empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT chuensengtan empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT chuensengtan empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT beechootai empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT beechootai empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT weeboontan empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT jiekiephang empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT ngiapchuantan empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT ngiapchuantan empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT cynthiayanlingtan empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT yanlingquah empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT davidkoot empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT hockhaiteo empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT lianlenglow empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT lianlenglow empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT lianlenglow empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT lianlenglow empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation
AT lianlenglow empoweringpatientswithdiabetesusingprofilingandtargetedfeedbacksdeliveredthroughsmartphoneappandwearableempowerprotocolforarandomizedcontrolledtrialoneffectivenessandimplementation